Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ZIOPHARM Oncology Inc (NASDAQ:ZIOP)

4.82
BATS BZX Real-Time Price
As of 3:50pm ET
 +0.155 / +3.33%
Today’s Change
4.45
Today|||52-Week Range
14.93
-42.06%
Year-to-Date
Today's Dead Cat Bounce Stock Is ZIOPHARM Oncology (ZIOP)
Jul 20 / TheStreet.com - Paid Partner Content
Why Fossil Group, Infosys, and Ziopharm Oncology Slumped Today
Jul 15 / MotleyFool.com - Paid Partner Content
ZIOPHARM (ZIOP) Stock Down on Patient Death in Phase I
Jul 18 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close4.66
Today’s open4.54
Day’s range4.54 - 4.94
Volume82,302
Average volume (3 months)2,500,274
Market cap$614.4M
Dividend yield--
Data as of 3:50pm ET, 07/26/2016

Growth & Valuation

Earnings growth (last year)-209.68%
Earnings growth (this year)+56.25%
Earnings growth (next 5 years)--
Revenue growth (last year)+215.51%
P/E ratioNM
Price/Sales240.58
Price/Book7.03

Competitors

 Today’s
change
Today’s
% change
HRTXHeron Therapeutics I...+0.06+0.36%
DVAXDynavax Technologies...-0.26-1.73%
CORTCorcept Therapeutics...-0.15-2.44%
PDLIPDL BioPharma Inc+0.04+1.15%
Data as of 3:50pm ET, 07/26/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$4.3M
Annual profit (last year)-$120.1M
Net profit margin-2,772.11%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Managing Director
Laurence James Neil Cooper
COO, Secretary, Chief Legal Officer &
Executive VP
Caesar J. Belbel
Corporate headquarters
Boston, Massachusetts

Forecasts

Partner Offers

Search for Jobs